These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2155138)

  • 1. Surgical implications of population screening for mammary carcinoma.
    Wobbes T
    Eur J Surg Oncol; 1990 Feb; 16(1):15-7. PubMed ID: 2155138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast carcinoma-in-situ: an emerging problem in Singapore.
    Chua CL; Tan PK; Chiang G; Soo KC; Low CH
    Singapore Med J; 1992 Aug; 33(4):383-5. PubMed ID: 1329232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Surgical treatment of non-palpable breast tumors].
    Lázár G; Ormándi K; Hajnal PR; Zöllei I; Szentpáli K; Paszt A; Kallai A; Kahán Z; Balogh A
    Orv Hetil; 2002 Jan; 143(2):77-81. PubMed ID: 11868452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late recurrence of ductal carcinoma in situ at the cutaneous end of surgical drainage following total mastectomy.
    Finkelstein SD; Sayegh R; Thompson WR
    Am Surg; 1993 Jul; 59(7):410-4. PubMed ID: 8391769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma.
    Hartman AR; Daniel BL; Kurian AW; Mills MA; Nowels KW; Dirbas FM; Kingham KE; Chun NM; Herfkens RJ; Ford JM; Plevritis SK
    Cancer; 2004 Feb; 100(3):479-89. PubMed ID: 14745863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Minimal carcinoma of the breast: incidence on mass screening].
    Virno F
    Minerva Chir; 1989 Feb; 44(3):399-400. PubMed ID: 2541373
    [No Abstract]   [Full Text] [Related]  

  • 7. Breast cancer risk factors: can we select women for prophylactic mastectomy?
    Schechter MT
    Can J Surg; 1985 May; 28(3):242-4, 247. PubMed ID: 2986806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraduct carcinoma of the breast (duct carcinoma in situ).
    Lange M; Kessel I; Kessler E; Lakier RH; Lange NR; Ross-Thompson S
    S Afr J Surg; 1994 Jun; 32(2):59-61. PubMed ID: 7502173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Conservative treatment of ductal carcinoma in situ of the breast].
    Hepp R; Baeza MR
    Rev Med Chil; 1999 Nov; 127(11):1345-50. PubMed ID: 10835721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous mastectomy and immediate prosthetic implantation as an alternative to simple mastectomy.
    Inglis FG; Midgley RD
    Can J Surg; 1974 Jan; 17(1):63-7. PubMed ID: 4359827
    [No Abstract]   [Full Text] [Related]  

  • 11. Should the hunt for nonpalpable breast lesions be called off?
    Wright CJ
    Can J Surg; 1986 Sep; 29(5):299-300. PubMed ID: 3756645
    [No Abstract]   [Full Text] [Related]  

  • 12. [Conservative surgery for ductal carcinoma in situ of the breast].
    Tersigni R; Mencacci R; Alessandroni L; Baiano G; Mardarella C; Parisi A
    Minerva Chir; 2003 Aug; 58(4):563-9. PubMed ID: 14603170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The surgeon and mass screening for breast cancer].
    Wobbes T; Tinnemans JG
    Ned Tijdschr Geneeskd; 1986 Nov; 130(47):2116-7. PubMed ID: 3025751
    [No Abstract]   [Full Text] [Related]  

  • 14. In situ carcinomas of the breast. Types, growth pattern, diagnosis, and treatment.
    Andersen J; Blichert-Toft M; Dyreborg U
    Eur J Surg Oncol; 1987 Apr; 13(2):105-11. PubMed ID: 3030823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surgical strategy in carcinoma of the breast in relation to the TNM].
    Badellino F; Canavese G
    Minerva Chir; 1988 Sep; 43(18 Suppl):13-5. PubMed ID: 2852315
    [No Abstract]   [Full Text] [Related]  

  • 16. Mammographic wire localization in diagnosis and treatment of occult carcinoma of breast.
    Petrovich JA; Ross DS; Sullivan JW; Lake TP
    Surg Gynecol Obstet; 1989 Mar; 168(3):239-43. PubMed ID: 2537536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of ductal carcinoma in situ by the pathologist: current questions].
    Arnould L; Caron Y; Sigal-Zafrani B
    Ann Pathol; 2003 Dec; 23(6):534-46. PubMed ID: 15094591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
    Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
    Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The non-palpable, radiographically suspicious breast lesion: an analysis of 101 cases.
    Perre CI; Hoynck van Papendrecht AA; Sierink HD; Muller JW
    Neth J Surg; 1990 Jun; 42(3):69-71. PubMed ID: 2164172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Guidelines for pathology--supplement to European guidelines for quality assurance in mammography screening. Report by the Pathology Working Group of the European Community].
    Sloane JP; Amendoeira I; Apostolikas N; Bellocq JP; Bianchi S; Böcker W; Bussolati G; Connolly CE; De Miguel C; Dervan P; Drijkoningen R; Elston CW; Faverly D; Gad A; Holland R; Jacquemier J; Lacerda M; Lindgren A; Martinez-Peñuela J; Peterse JL; Rank F; Tsakraklides V; de Wolf C; Zafrani B
    Pathologe; 1997 Jan; 18(1):71-88. PubMed ID: 9157408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.